Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Lancaster

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2016
Subtype-specific therapy for autoimmune neuropathies?Eric Lancaster, Steven S Scherer
Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2018
Anti-NMDAR encephalitis in a patient with Crohn disease receiving adalimumabGeoffrey P Noble, Eric Lancaster
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinomaCen Zhang, Lyndsey Emery, Eric Lancaster
Neurology|July 13, 2011
Encephalitis and antibodies to synaptic and neuronal cell surface proteinsEric Lancaster, Eugenia Martinez-Hernandez, Josep Dalmau
JAMA Neurology|June 9, 2015
Diagnosing Encephalitis, Not Otherwise SpecifiedZhi-Li Wang, Eric Lancaster, Li Yang
Annals of Neurology|December 16, 2017
Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotoniaKristina R Patterson, Josep Dalmau, Eric Lancaster
Muscle & Nerve|December 8, 2020
Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumorAlexander J Gill, Shreya Gandhy, Eric Lancaster
Neuroscience Letters|April 10, 2019
ADAM23 is a negative regulator of K<sub>v</sub>1.1/K<sub>v</sub>1.4 potassium currentsEunjoo Lancaster, Elisabeth Burnor, Junxian Zhang, et al.
Muscle & Nerve|November 18, 2009
A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1BEric Lancaster, Lauren B Elman, Steven S Scherer
The Journal of Physiology|April 17, 2002
Calcium and calcium-activated currents in vagotomized rat primary vagal afferent neuronsEric Lancaster, Eun Joo Oh, Tony Gover, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2016
Subtype-specific therapy for autoimmune neuropathies?Eric Lancaster, Steven S Scherer
Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2018
Anti-NMDAR encephalitis in a patient with Crohn disease receiving adalimumabGeoffrey P Noble, Eric Lancaster
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinomaCen Zhang, Lyndsey Emery, Eric Lancaster
Neurology|July 13, 2011
Encephalitis and antibodies to synaptic and neuronal cell surface proteinsEric Lancaster, Eugenia Martinez-Hernandez, Josep Dalmau
JAMA Neurology|June 9, 2015
Diagnosing Encephalitis, Not Otherwise SpecifiedZhi-Li Wang, Eric Lancaster, Li Yang
Annals of Neurology|December 16, 2017
Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotoniaKristina R Patterson, Josep Dalmau, Eric Lancaster
Muscle & Nerve|December 8, 2020
Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumorAlexander J Gill, Shreya Gandhy, Eric Lancaster
Neuroscience Letters|April 10, 2019
ADAM23 is a negative regulator of K<sub>v</sub>1.1/K<sub>v</sub>1.4 potassium currentsEunjoo Lancaster, Elisabeth Burnor, Junxian Zhang, et al.
Muscle & Nerve|November 18, 2009
A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1BEric Lancaster, Lauren B Elman, Steven S Scherer
The Journal of Physiology|April 17, 2002
Calcium and calcium-activated currents in vagotomized rat primary vagal afferent neuronsEric Lancaster, Eun Joo Oh, Tony Gover, et al.
Pageof 7